학술논문
Bendamustine and rituximab as induction therapy in both transplant-eligible and -ineligible patients with mantle cell lymphoma
Document Type
Article
Author
Source
In Blood Advances 11 August 2020 4(15):3486-3494
Subject
Language
ISSN
2473-9529